|
CCNJ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.780000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.142200E-02 |
| Normal-vs-Stage2 |
2.560400E-01 |
| Normal-vs-Stage3 |
1.097780E-01 |
| Normal-vs-Stage4 |
3.492800E-01 |
| Stage1-vs-Stage2 |
6.877400E-01 |
| Stage1-vs-Stage3 |
5.690400E-01 |
| Stage1-vs-Stage4 |
7.578600E-01 |
| Stage2-vs-Stage3 |
9.775800E-01 |
| Stage2-vs-Stage4 |
9.507400E-01 |
| Stage3-vs-Stage4 |
9.577800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.556100E-02 |
| Normal-vs-AfricanAmerican |
2.088100E-02 |
| Normal-vs-Asian |
2.212600E-01 |
| Caucasian-vs-AfricanAmerican |
4.287800E-01 |
| Caucasian-vs-Asian |
9.467800E-01 |
| AfricanAmerican-vs-Asian |
8.359400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.326400E-01 |
| Normal-vs-Female |
7.85640000000587E-05 |
| Male-vs-Female |
1.202050E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.136600E-01 |
| Normal-vs-Extreme_Weight |
4.725000E-01 |
| Normal-vs-Obese |
1.862500E-02 |
| Normal-vs-Extreme_Obese |
8.134200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.475200E-01 |
| Normal_Weight-vs-Obese |
3.361400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.941800E-01 |
| Extreme_Weight-vs-Obese |
8.182200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.599800E-01 |
| Obese-vs-Extreme_Obese |
3.145400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.164900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.612200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.893990E-01 |
| Normal-vs-Age(81-100Yrs) |
2.865600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.111400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.433600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.044200E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.533900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.103180E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.720000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.304800E-03 |
| Normal-VS-Type2 PRCC |
3.574200E-01 |
| Normal-VS-KIRP CIMP |
1.350510E-04 |
| Normal-VS-Unclassified PRCC |
4.388200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.041160E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.001820E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.045200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.198600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.245510E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.913400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.986400E-01 |
| Normal-vs-N1 |
2.898600E-03 |
| Normal-vs-N2 |
6.068000E-01 |
| N0-vs-N1 |
2.298400E-03 |
| N0-vs-N2 |
4.293000E-01 |
| N1-vs-N2 |
3.845000E-01 |
|
|
